CA Stock MarketDetailed Quotes
AGN Algernon Pharmaceuticals Inc
- 0.075
- +0.005+7.14%
15min DelayMarket Closed Jan 7 15:59 ET
1.60MMarket Cap-2.50P/E (TTM)
0.075High0.070Low94.00KVolume0.070Open0.070Pre Close6.71KTurnover0.16552wk High0.52%Turnover Ratio21.30MShares0.06052wk Low-0.03EPS TTM1.35MFloat Cap27.500Historical HighLossP/E (Static)17.96MShs Float0.050Historical Low-0.03EPS LYR7.14%Amplitude--Dividend TTM0.74P/B1Lot Size--Div YieldTTM
Algernon Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -53.99%2.41M | -57.38%420.2K | -58.72%465.66K | -19.52%1M | -72.24%521.97K | -12.92%5.24M | -54.80%985.85K | 40.80%1.13M | -32.06%1.25M | 56.56%1.88M |
| Selling and administrative expenses | -57.54%1.76M | -51.70%385.17K | -46.64%356.12K | -42.54%665.2K | -76.75%354.4K | 11.28%4.15M | -41.64%797.49K | -6.51%667.45K | 8.02%1.16M | 165.39%1.52M |
| -Selling and marketing expense | -74.51%321.35K | -32.94%145.99K | -80.74%29.95K | -86.89%40.55K | -81.87%104.86K | 72.75%1.26M | -35.93%217.7K | 26.41%155.55K | 148.79%309.16K | 305.26%578.3K |
| -General and administrative expense | -50.12%1.44M | -58.75%239.18K | -36.28%326.17K | -26.39%624.65K | -73.62%249.54K | -3.69%2.89M | -43.53%579.79K | -13.37%511.91K | -10.44%848.58K | 119.15%945.86K |
| Research and development costs | -40.54%651.16K | -81.40%35.03K | -76.22%109.53K | 276.45%339.01K | -52.95%167.58K | -52.25%1.1M | -76.88%188.36K | 427.98%460.58K | -88.22%90.06K | -43.17%356.17K |
| Operating profit | 53.99%-2.41M | 57.38%-420.2K | 58.72%-465.66K | 19.52%-1M | 72.24%-521.97K | 12.92%-5.24M | 54.80%-985.85K | -40.80%-1.13M | 32.06%-1.25M | -56.56%-1.88M |
| Net non-operating interest income (expenses) | -34.76%1.37K | -65.83%260 | -48.23%380 | 0.00%308 | 42.86%420 | 0.91%2.1K | 64.01%761 | 33.45%734 | -48.58%308 | -36.77%294 |
| Non-operating interest income | -34.76%1.37K | -65.83%260 | -48.23%380 | 0.00%308 | 42.86%420 | 0.91%2.1K | 64.01%761 | 33.45%734 | -48.58%308 | -36.77%294 |
| Other net income (expenses) | 223.77%1.91M | -1.49K | 1.91M | -4,125.19%-1.54M | ||||||
| Special income (charges) | 115.93%245.46K | --0 | --245.46K | ---- | ---- | -4,125.19%-1.54M | ---1.54M | --0 | ---- | ---- |
| -Less:Impairment of capital assets | --0 | ---- | ---- | ---- | ---- | 4,125.19%1.54M | ---- | ---- | ---- | ---- |
| -Less:Other special charges | ---245.46K | --0 | ---245.46K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | --1.66M | ---1.49K | --1.66M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 92.58%-502.98K | 83.32%-421.43K | 228.09%1.44M | 19.53%-1M | 72.26%-521.55K | -12.01%-6.78M | -13.95%-2.53M | -40.80%-1.13M | 32.05%-1.25M | -56.60%-1.88M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 92.58%-502.98K | 83.32%-421.43K | 228.09%1.44M | 19.53%-1M | 72.26%-521.55K | -12.01%-6.78M | -13.95%-2.53M | -40.80%-1.13M | 32.05%-1.25M | -56.60%-1.88M |
| Net income continuous operations | 92.58%-502.98K | 83.32%-421.43K | 228.09%1.44M | 19.53%-1M | 72.26%-521.55K | -12.01%-6.78M | -13.95%-2.53M | -40.80%-1.13M | 32.05%-1.25M | -56.60%-1.88M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 92.58%-502.98K | 83.32%-421.43K | 228.09%1.44M | 19.53%-1M | 72.26%-521.55K | -12.01%-6.78M | -13.95%-2.53M | -40.80%-1.13M | 32.05%-1.25M | -56.60%-1.88M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 92.58%-502.98K | 83.32%-421.43K | 228.09%1.44M | 19.53%-1M | 72.26%-521.55K | -12.01%-6.78M | -13.95%-2.53M | -40.80%-1.13M | 32.05%-1.25M | -56.60%-1.88M |
| Diluted earnings per share | 93.33%-0.03 | 90.36%-0.0154 | 170.00%0.07 | 61.54%-0.05 | 85.00%-0.03 | 48.28%-0.45 | 44.78%-0.1601 | 16.67%-0.1 | 51.85%-0.13 | -32.62%-0.2 |
| Basic earnings per share | 93.33%-0.03 | 90.36%-0.0154 | 160.00%0.06 | 61.54%-0.05 | 85.00%-0.03 | 48.28%-0.45 | 44.78%-0.1601 | 16.67%-0.1 | 51.85%-0.13 | -32.62%-0.2 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data